Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA PMA

diaphragmatic/phrenic nerve laparoscopically-implanted stimulator

PMA Number: P200018 · 2023-03-31

ApplicantSynapse Biomedical, Inc.
Decision Date2023-03-31
PMA NumberP200018
Product CodeOIR
Device ClassClass 3
Medical SpecialtyU
Advisory CommitteeAN

Device Summary

diaphragmatic/phrenic nerve laparoscopically-implanted stimulator is the device name listed in this FDA 510(k) record. The listed applicant is Synapse Biomedical, Inc.. It received FDA 510(k) clearance on 2023-03-31. The device is classified under product code OIR. It was reviewed by the AN advisory panel.

Frequently Asked Questions

What is the diaphragmatic/phrenic nerve laparoscopically-implanted stimulator?

diaphragmatic/phrenic nerve laparoscopically-implanted stimulator is a medical device that received FDA 510(k) clearance on 2023-03-31. The listed applicant is Synapse Biomedical, Inc..

When did diaphragmatic/phrenic nerve laparoscopically-implanted stimulator receive FDA 510(k) clearance?

The clearance date for diaphragmatic/phrenic nerve laparoscopically-implanted stimulator can be found in the official FDA records.

Who is the listed applicant for diaphragmatic/phrenic nerve laparoscopically-implanted stimulator?

The FDA 510(k) record lists Synapse Biomedical, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for diaphragmatic/phrenic nerve laparoscopically-implanted stimulator?

The FDA product code for diaphragmatic/phrenic nerve laparoscopically-implanted stimulator is OIR.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT04745156A Study Using Brain Stimulation and Behavioral Therapy to Increase Extent of Resection in Low-Grade GliomasNOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑